Evidence map›Paper›PMID 42647004›Full record

ArticleToxics2026

Effects of Per- and Polyfluoroalkyl Substances (PFAS) Exposure Reduction on Serum Lipids in the Copenhagen City Heart Study: A Protocol for an Observational Cohort Study Emulating a Target Trial.

Georges Khoury, Laura Deen, Lars Christian Lund, Erich Batzella, Michelle C Turner, Gorm Boje Jensen, Tina Kold Jensen, Sandra Søgaard Tøttenborg

Abstract read
In one paragraph

Article in Toxics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Georges KhouryDepartment of Occupational and Environmental Medicine, Copenhagen University Hospital-Bispebjerg and Frederiksberg, 1014 Copenhagen, Denmark.ORCID 0000-0003-4775-4240
Laura DeenDepartment of Occupational and Environmental Medicine, Copenhagen University Hospital-Bispebjerg and Frederiksberg, 1014 Copenhagen, Denmark.ORCID 0000-0003-4443-7098
Lars Christian LundClinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, 5230 Odense, Denmark.ORCID 0000-0001-8651-6072
Erich BatzellaClinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, 5230 Odense, Denmark.ORCID 0000-0001-6849-7920
Michelle C TurnerBarcelona Institute for Global Health (ISGlobal), Barcelona, Spain.ORCID 0000-0002-6431-1997
Gorm Boje JensenCopenhagen City Heart Study, Department of Occupational and Environmental Medicine, Bispebjerg Hospital, Copenhagen, Denmark.ORCID 0000-0002-8925-663X
Tina Kold JensenClinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, 5230 Odense, Denmark.ORCID 0000-0003-2311-5778
Sandra Søgaard TøttenborgDepartment of Occupational and Environmental Medicine, Copenhagen University Hospital-Bispebjerg and Frederiksberg, 1014 Copenhagen, Denmark.ORCID 0000-0001-7742-4360

Funding

European Research Council Project: 101141686 - ERC-2023-ADGIndependent Research Fund Denmark 3165-00045B
6 · The paper itself

Abstract

Per- and polyfluoroalkyl substances (PFAS) are environmental contaminants associated with higher serum lipids, although primarily in cross-sectional studies, limiting causal inference. We aim to determine whether there is a causal relationship between PFAS and serum lipid levels by emulating a target trial of a hypothetical PFAS-reduction intervention using observational data. The target trial would enroll adults aged ≥20 years without prior cardiovascular, kidney, or liver disease, diabetes, or use of related medications. Participants would be randomly assigned to either PFAS-reduction counseling or no counseling, with adherence evaluated after 10 years, and then followed up after 10 years to assess effects on serum lipids. To emulate the target trial, we will use data from the Copenhagen City Heart Study on three successive clinical visits: baseline, follow-up, and outcome assessment visit, 10 years apart. Eligible participants meet the target trial criteria, have available blood samples for PFAS quantification at follow-up, and information on serum lipids at the outcome assessment. Intervention strategies will be evaluated based on observed reductions in PFAS concentrations between baseline and follow-up visit. Serum lipids are assessed at the outcome assessment visit. The emulation assumes exchangeability by adjusting for baseline and time-varying confounders using G-computation. This protocol explores applying the target trial emulation framework to improve causal inference in environmental epidemiology.

Indexed as

adultscardiometabolic healthcausal inferencecohortPFASserum lipidstarget trial emulation

Identifiers

PMID42647004
PMCPMC13517899

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.